Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells (Q37600964)
Jump to navigation
Jump to search
scientific article published on September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells |
scientific article published on September 2009 |
Statements
1 reference
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells (English)
1 reference
Andrew J Rech
1 reference
Robert H Vonderheide
1 reference
1 September 2009
1 reference
1 reference
1 reference
Identifiers
1 reference